Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption.

Schimke I, Müller J, Priem F, Kruse I, Schön B, Stein J, Kunze R, Wallukat G, Hetzer R.

J Am Coll Cardiol. 2001 Jul;38(1):178-83.

3.

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy.

Müller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R.

Circulation. 2000 Feb 1;101(4):385-91.

4.

Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.

Staudt A, Böhm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB.

Circulation. 2002 Nov 5;106(19):2448-53.

5.

Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy.

Yücel D, Aydoğdu S, Seneş M, Topkaya BC, Nebioğlu S.

Scand J Clin Lab Invest. 2002;62(6):463-8.

PMID:
12469901
6.

Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress.

Kishimoto C, Shioji K, Kinoshita M, Iwase T, Tamaki S, Fujii M, Murashige A, Maruhashi H, Takeda S, Nonogi H, Hashimoto T.

Int J Cardiol. 2003 Oct;91(2-3):173-8.

PMID:
14559127
7.

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.

Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K.

J Am Coll Cardiol. 2002 Feb 20;39(4):646-52.

8.

The relationship between potency of oxidative stress and severity of dilated cardiomyopathy.

Demirbag R, Yilmaz R, Erel O, Gultekin U, Asci D, Elbasan Z.

Can J Cardiol. 2005 Aug;21(10):851-5.

PMID:
16107908
9.

Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment.

Bergesio F, Monzani G, Guasparini A, Ciuti R, Gallucci M, Cristofano C, Castrignano E, Cupisti A, Barsotti G, Marcucci R, Abbate R, Bandini S, Gallo M, Tosi PL, Salvadori M.

Clin Nephrol. 2005 Aug;64(2):103-12.

PMID:
16114786
10.

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy.

Tsutamoto T, Wada A, Matsumoto T, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Yamamoto T, Horie H, Sugimoto Y, Kinoshita M.

J Am Coll Cardiol. 2001 Jun 15;37(8):2086-92.

11.

Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.

Székely E, Vereckei A, Almási A, Rapavi E, Tasnádi G, Várnai K, Pallai Z, Lugasi A, Blázovics A.

Clin Hemorheol Microcirc. 2007;36(1):13-23.

PMID:
17211058
12.

Increased oxidative stress in dilated cardiomyopathic heart failure.

Yücel D, Aydoğdu S, Cehreli S, Saydam G, Canatan H, Seneş M, Ciğdem Topkaya B, Nebioğlu S.

Clin Chem. 1998 Jan;44(1):148-54.

13.

Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.

Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Hardt S, Goeser S, Kaya Z, Katus HA, Dengler TJ.

J Clin Apher. 2009;24(4):141-9. doi: 10.1002/jca.20204.

PMID:
19591221
14.

Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.

Staudt A, Dörr M, Staudt Y, Böhm M, Probst M, Empen K, Plötz S, Maschke HE, Hummel A, Baumann G, Felix SB.

Am Heart J. 2005 Oct;150(4):729-36.

PMID:
16209975
15.

Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.

Girona J, Manzanares JM, Marimón F, Cabré A, Heras M, Guardiola M, Ribalta J, Masana L.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):380-7.

PMID:
17904830
16.

Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.

Staudt A, Schäper F, Stangl V, Plagemann A, Böhm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB.

Circulation. 2001 Jun 5;103(22):2681-6.

17.
19.

Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).

Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A.

J Clin Gastroenterol. 2006 Nov-Dec;40(10):930-5.

PMID:
17063114
20.

Oxidative stress and non-enzymatic glycation in IgA nephropathy.

Vas T, Wagner Z, Jenei V, Varga Z, Kovács T, Wittmann I, Schinzel R, Balla G, Balla J, Heidland A, Nagy J.

Clin Nephrol. 2005 Nov;64(5):343-51.

PMID:
16312261
Items per page

Supplemental Content

Support Center